242
Participants
Start Date
April 30, 2004
Primary Completion Date
December 31, 2009
Study Completion Date
December 31, 2009
Lopinavir ritonavir
400mg BD 100mg BD
Atazanavir ritonavir
300mg QD 100mg QD
Efavirenz
600mg QD
Department of Infectious Diseases, Gothenburg
Göteborg University
OTHER